With early ties to the Medical College of Wisconsin and involving - on the team - investigators with other academic institutions, Cytegen Corporation is organized around development of discovery platform designed to increase the human healthspan by reversing age-related decline in the body. Principals of the firm have discovered chemicals that promote the elimination of defective mitochondria while promoting the creation of new, healthy mitochondria - therevy enablng doctors to use genomes, proteomics, and biochemical data to optimize cellular metabolism. Focused on the link between mitochondrial dysfunction and aging along with neurodegenerative disorders such as Parkinsons and Alzheimers, the company's therapies target age-related health decline along some other rare diseases with the objective of enabling patients to improve cellular metabolism. to prevent neurodegenerative diseases, and/or effectively to reverse age related illness. The firm describe themsleves as having identified unique pathways that impact mitochondrial fitness and demonstrated recovery of cardiovascular and neurological function via therapeutic intervention.
